Table 7.

Changes from baseline in cardiovascular risk factors for participants with baseline C-reactive protein ≤ 4 mg/l (Mean values with their standard errors)

Parameters	Sample size (cranberry/placebo)	Cranberry		Placebo		P
		Mean	se	Mean	se
Weight (kg)	8/10	−0·45	0·79	0·04	0·71	0·65
Systolic BP (mmHg)	8/10	−2·88	2·63	0·5	2·35	0·35
Diastolic BP (mmHg)	8/10	−0·63	2·21	−1·8	1·98	0·70
Glucose disposal rate (mg/kg × min)	8/10	0·27	0·4	0·04	0·36	0·68
Fasting glucose (mmol/l)	8/10	0·06	0·15	0·01	0·13	0·80
2-h glucose (mmol/l)	8/10	−0·72	0·70	0·07	0·63	0·41
RHI from EndoPAT	8/10	−0·14	0·16	−0·06	0·14	0·71
RMR	8/10	−50·25	24·44	−7·4	21·86	0·21
Total cholesterol (% change)	8/10	−13·76	4·47	−6·08	4	0·22
LDL (% change)	8/10	−15·4	6·31	−3·92	5·28	0·18
HDL (% change)	8/10	−20·15	3·45	−14·44	3·09	0·24
TAG (% change)	8/10	−3·78	9·81	4·62	8·78	0·53

BP, blood pressure; RHI, reactive hyperaemia index.